Biel News!
Watch Shares of BIEL closely
Written by Staff and Wire Reports
Monday, 28 September 2009 13:49
Make a note to keep an eye on shares of BioElectronics (OTC:BIEL) starting tomorrow morning, as the company has been working with the Pinksheets to remove the 'Caveat Emptor' notice which has prevented the stock from trading to it's maximum potential the last few weeks.
As we understand it, the company has submitted sustantial amounts of paperwork in order to get the trading exchange to have their status changed to "Fully Reporting" and they expect that the change may happen at any moment.
Shares would be expected to rise upon that development as they would upon any news regarding the company's application to the FDA. An approval decision from the agency is also expected any day.
BioElectronics Corporation (BioElectronics) designs, develops and markets a variety of drug-free, anti-inflammatory patches for a range of medical indications. The Company's patch products, which are marketed under the name ActiPatch Therapy, deliver pulsed electromagnetic field therapy, an anti-inflammatory and pain relief therapy.
The ActiPatch Therapy products combine a miniaturized microchip, power source and antenna in a soft, flexible outer envelope. When applied to the body, these devices deliver a pulsed radio frequency signal into the body on a 27 megahertz (MHz) frequency wave that induces a low frequency electromagnetic field to damaged cell tissue.
AI
